KRS Global Biotechnology, Inc. Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility
Share:
Summary
- Company Announcement Date:
- FDA Publish Date:
- Product Type:
- Animal & Veterinary
- Reason for Announcement:
-
Lack of sterility assurance
- Company Name:
- KRS Global Biotechnology
- Brand Name:
-
KRS Global Biotechnology
- Product Description:
-
Animal Sterile Drug Products
Company Announcement
KRS Global Biotechnology, Inc. is voluntarily recalling all lots of unexpired human and animal drugs intended to be sterile to the consumer level. The products are being recalled due to lack of assurance of sterility.
Administration of a drug product intended to be sterile that is not sterile could result in serious infections which may be life-threatening. To date, KRS Global Biotechnology, Inc. has not received any reports of adverse events related to this recall.
The affected products are listed below and include a lot number and expiration date. The products can be identified by a KRS Global Biotechnology, Inc. label. Products were distributed nationwide to hospitals, doctor’s offices, surgical centers, pharmacies, veterinarians and patients.
KRS Global Biotechnology, Inc. is notifying its customers by mail, telephone, or email and is arranging for credit of all recalled products.
Health Care Providers that have these products which are being recalled should stop using them and return to KRS Global Biotechnology, Inc.
Consumers that have these products which are being recalled should stop using them and contact their doctor or health care provider.
Consumers with questions regarding this recall can contact KRS Global Biotechnology, Inc. by phone 888-398-9950 or recall@krsbio.com. We are available Monday through Friday from 9 AM to 5 PM EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
| Product | Lot Number | Expiration |
|---|---|---|
| ALPHA LIPOIC ACID (PF), COMPOUNDED 25MG/ML INJ 30 ML | 07242019@6 | 10/22/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 06182019@4 | 9/16/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 07182019@2 | 10/16/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 07192019@5 | 10/17/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 07232019@2 | 10/21/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 07262019@5 | 10/24/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 07272019@2 | 10/25/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) (PF) 500 MG/ML INJ 50 ML | 07292019@17 | 10/27/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) W/ PRESERVATIVE 500MG/ML INJ 50 ML | 07152019@4 | 10/13/2019 |
| ASCORBIC ACID (TAPIOCA SOURCE) W/ PRESERVATIVE 500MG/ML INJ 50 ML | 07172019@2 | 10/15/2019 |
| BACTERIOSTATIC WATER (0.9% BENZYL ALCOHOL ) COMPOUNDED INJ 30 ML | 04302019@2 | 9/27/2019 |
| BACTERIOSTATIC WATER (0.9% BENZYL ALCOHOL ) COMPOUNDED INJ 30 ML | 05082019@2 | 10/5/2019 |
| BACTERIOSTATIC WATER (0.9% BENZYL ALCOHOL ) COMPOUNDED INJ 30 ML | 05302019@5 | 10/27/2019 |
| BACTERIOSTATIC WATER (0.9% BENZYL ALCOHOL ) COMPOUNDED INJ 30 ML | 06192019@2 | 11/16/2019 |
| BIMIX #3 (PAPAVERINE/PHENTOLAMINE) 30MG/3MG/ML INJ 5 ML | 04042019@7 | 10/1/2019 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 01212019@2 | 10/18/2019 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 07242019@3 | 10/22/2019 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 02212019@5 | 11/18/2019 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 03192019@2 | 12/14/2019 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 03282019@28 | 12/23/2019 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 05152019@9 | 2/9/2020 |
| CARNITINE (L) 170MG/ML INJ 27 ML, COMPOUNDED | 06062019@2 | 3/2/2020 |
| CARNITINE (L) 75MG/ML INJ 27 ML, COMPOUNDED | 03282019@2 | 9/24/2019 |
| CARNITINE (L) 75MG/ML INJ 27 ML, COMPOUNDED | 05162019@5 | 11/12/2019 |
| CARNITINE (L) 75MG/ML INJ 27 ML, COMPOUNDED | 05312019@10 | 11/27/2019 |
| CARNITINE (L) 75MG/ML INJ 27 ML, COMPOUNDED | 07172019@5 | 1/13/2020 |
| ePHEDrine Sulfate 50mg/5mL (10mg/mL) in 0.9% Sod Cl. (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 07192019@13 | 10/2/2019 |
| ePHEDrine Sulfate 50mg/5mL (10mg/mL) in 0.9% Sod Cl. (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 07222019@7 | 10/5/2019 |
| ePHEDrine Sulfate 50mg/5mL (10mg/mL) in 0.9% Sod Cl. (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 08152019@11 | 10/29/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 05242019@11 | 9/21/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 05242019@12 | 9/21/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 06272019@3 | 10/25/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 06272019@4 | 10/25/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 07192019@14 | 11/16/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 07262019@9 | 11/23/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 08072019@11 | 12/5/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 08072019@10 | 12/5/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 08162019@20 | 12/14/2019 |
| ePHEDrine Sulfate in 0.9% Sod Chl 25mg/5mL (5mg/mL) (PF) 5mL fill in a 6mL Sing Dose Syr Compounded | 08162019@19 | 12/14/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 05232019@15 | 9/20/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 05232019@16 | 9/20/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 05292019@19 | 9/26/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 05312019@33 | 9/28/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 06042019@17 | 10/2/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 06122019@12 | 10/10/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 06122019@13 | 10/10/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 06122019@11 | 10/10/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 07192019@12 | 11/16/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 07192019@18 | 11/16/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 07262019@8 | 11/23/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 08202019@4 | 12/18/2019 |
| ePHEDrine Sulfate in 0.9% Sod Cl 50mg/10mL (5mg/mL)(PF) 10mL fill in a 12mL Single Dose Syr Compound | 08212019@13 | 12/19/2019 |
| fentaNYL Citrate 1,000 mcg/100mL (10 mcg/mL)in 0.9% Sod Cl. (PF) 100mL fill in 150mL IV Bag Compound | 06282019@15 | 9/26/2019 |
| fentaNYL Citrate 1,000 mcg/100mL (10 mcg/mL)in 0.9% Sod Cl. (PF) 100mL fill in 150mL IV Bag Compound | 07272019@12 | 10/25/2019 |
| fentaNYL Citrate 2,000mcg/100mL (20mcg/mL)(Preservative Free)100mL fill in a 150mL IV Bag Compounded | 07162019@15 | 10/14/2019 |
| fentaNYL Citrate 2,000mcg/100mL (20mcg/mL)(Preservative Free)100mL fill in a 150mL IV Bag Compounded | 07262019@10 | 10/24/2019 |
| fentaNYL Citrate 2,500 mcg/100mL (25mcg/mL)in 0.9% Sod Cl (PF) 100mL fill in a 150mL IV Bag Compound | 06142019@22 | 9/12/2019 |
| fentaNYL Citrate 2,500 mcg/100mL (25mcg/mL)in 0.9% Sod Cl (PF) 100mL fill in a 150mL IV Bag Compound | 06142019@21 | 9/12/2019 |
| fentaNYL Citrate 2,500 mcg/100mL (25mcg/mL)in 0.9% Sod Cl (PF) 100mL fill in a 150mL IV Bag Compound | 07162019@14 | 10/14/2019 |
| fentaNYL Citrate 2,500 mcg/100mL (25mcg/mL)in 0.9% Sod Cl (PF) 100mL fill in a 150mL IV Bag Compound | 07262019@7 | 10/24/2019 |
| fentaNYL Citrate 2,500 mcg/100mL (25mcg/mL)in 0.9% Sod Cl (PF) 100mL fill in a 150mL IV Bag Compound | 08162019@3 | 11/14/2019 |
| FLUORESCEIN (PF), COMPOUNDED 500 MG/VIAL LYOPHILIZED 10ML | 04012019@45 | 9/28/2019 |
| GLUTATHIONE, COMPOUNDED 200MG/ML INJ 30 ML | 07192019@2 | 10/17/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 06202019@6 | 9/18/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 06282019@5 | 9/26/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 06282019@7 | 9/26/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 07292019@5 | 10/27/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 07292019@7 | 10/27/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 08062019@8 | 11/4/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 08132019@6 | 11/7/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 08122019@8 | 11/10/2019 |
| Glycopyrrolate 0.6mg/3mL (0.2mg/mL) (PF) 3mL Single Dose Syringe, Compounded | 08202019@6 | 11/18/2019 |
| Glycopyrrolate 1mg/5mL (0.2mg/mL) (PF) 5mL fill in a 6mL Single Dose Syringe, Compounded | 07222019@9 | 10/20/2019 |
| Glycopyrrolate 1mg/5mL (0.2mg/mL) (PF) 5mL fill in a 6mL Single Dose Syringe, Compounded | 08202019@8 | 11/18/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 11,000 IU LYOPHILIZED | 03182019@1 | 9/14/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 11,000 IU LYOPHILIZED | 04242019@1 | 10/21/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 11,000 IU LYOPHILIZED | 06032019@3 | 11/30/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 20,000 IU LYOPHILIZED | 03252019@11 | 9/21/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 20,000 IU LYOPHILIZED | 04232019@1 | 10/20/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 20,000 IU LYOPHILIZED | 05232019@6 | 11/19/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 20,000 IU LYOPHILIZED | 06132019@1 | 12/10/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 5,000 IU LYOPHILIZED | 05232019@2 | 11/19/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 6,000 IU LYOPHILIZED, COMPOUNDED | 04022019@3 | 9/29/2019 |
| HCG – HUMAN CHORIONIC GONADOTROPIN 6,000 IU LYOPHILIZED, COMPOUNDED | 04162019@4 | 10/13/2019 |
| Hyaluronidase 150 units/mL (Preservative Free) 3mL fill in a 5mL SDV, Compounded | 07202019@10 | 10/18/2019 |
| HYDROXOCOBALAMIN 0.5 MG/ML, INJ 10 ML COMPOUNDED | 06052019@7 | 10/3/2019 |
| HYDROXOCOBALAMIN 0.5 MG/ML, INJ 20 ML COMPOUNDED | 06062019@7 | 10/4/2019 |
| HYDROXOCOBALAMIN 1 MG/ML INJ 30 ML COMPOUNDED | 07142019@2 | 11/11/2019 |
| HYDROXOCOBALAMIN 1 MG/ML INJ 30 ML COMPOUNDED | 07152019@1 | 11/12/2019 |
| Isoproterenol HCl 200mcg/50mL (4mcg/mL) (PF)(Contains Sulfites) in D5W 50mL IV Bag, Compounded | 07202019@6 | 9/18/2019 |
| Isoproterenol HCl 200mcg/50mL (4mcg/mL) (PF)(Contains Sulfites) in D5W 50mL IV Bag, Compounded | 08192019@6 | 10/18/2019 |
| Ketamine HCl 10mg/1mL (10mg/mL)(PF) in 0.9% Sodium Cl. 1mL fill in a 3mL Single Dose Syr, Compounded | 07202019@9 | 10/18/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 06192019@14 | 9/17/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 06272019@2 | 9/25/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 07142019@11 | 10/12/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 07172019@10 | 10/15/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 07242019@13 | 10/22/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 07292019@10 | 10/27/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 07292019@12 | 10/27/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 08122019@16 | 11/10/2019 |
| Ketamine HCl 50mg/5mL (10mg/mL) (1%)(PF) in 0.9% Sod. Cl. 5mL fill in a 6mL Single Dose Syr Compound | 08142019@8 | 11/12/2019 |
| Labetalol Hydrochloride 20mg/4 mL (5mg/mL) 4mL fill in a 6mL Single Dose Syringe, Compounded | 07152019@12 | 9/13/2019 |
| Labetalol Hydrochloride 20mg/4 mL (5mg/mL) 4mL fill in a 6mL Single Dose Syringe, Compounded | 07192019@16 | 9/17/2019 |
| Labetalol Hydrochloride 20mg/4 mL (5mg/mL) 4mL fill in a 6mL Single Dose Syringe, Compounded | 08082019@10 | 10/7/2019 |
| Labetalol Hydrochloride 20mg/4 mL (5mg/mL) 4mL fill in a 6mL Single Dose Syringe, Compounded | 08122019@11 | 10/11/2019 |
| Labetalol Hydrochloride 20mg/4 mL (5mg/mL) 4mL fill in a 6mL Single Dose Syringe, Compounded | 08142019@13 | 10/13/2019 |
| L-ASPARAGINASE, COMPOUNDED STERILE 10,000 U/VIAL LYOPHILIZED | 04012019@1 | 9/28/2019 |
| L-ASPARAGINASE, COMPOUNDED STERILE 10,000 U/VIAL LYOPHILIZED | 05212019@50 | 11/17/2019 |
| L-ASPARAGINASE, COMPOUNDED STERILE 10,000 U/VIAL LYOPHILIZED | 05242019@4 | 11/20/2019 |
| Lidocaine 0.75%/Epinephrine 0.025% (PF)(Sulfite Free) in BSS Opth Inj. 1mL in a 3mL Syr, Compounded | 08022019@8 | 9/16/2019 |
| Lidocaine 0.75%/Epinephrine 0.025% (PF)(Sulfite Free) in BSS Opth Inj. 1mL in a 3mL Syr, Compounded | 08052019@6 | 9/19/2019 |
| Lidocaine 0.75%/Epinephrine 0.025% (PF)(Sulfite Free) in BSS Opth Inj. 1mL in a 3mL Syr, Compounded | 08122019@3 | 9/26/2019 |
| Lidocaine 0.75%/Epinephrine 0.025% (PF)(Sulfite Free) in BSS Opth Inj. 1mL in a 3mL Syr, Compounded | 08192019@5 | 10/3/2019 |
| LIDOcaine HCl (Preservative Free) 10mg/mL (1%) 5mL Fill in a 6mL Single-Dose Syringe, Compounded | 07182019@7 | 10/16/2019 |
| LIDOcaine HCl (Preservative Free) 10mg/mL (1%) 5mL Fill in a 6mL Single-Dose Syringe, Compounded | 08152019@7 | 11/13/2019 |
| LIDOcaine HCl (Preservative Free) 20mg/mL (2%) 5mL Fill in a 6mL Single-Dose Syringe, Compounded | 06142019@9 | 9/12/2019 |
| LIDOcaine HCl (Preservative Free) 20mg/mL (2%) 5mL Fill in a 6mL Single-Dose Syringe, Compounded | 06212019@35 | 9/19/2019 |
| LIDOcaine HCl (Preservative Free) 20mg/mL (2%) 5mL Fill in a 6mL Single-Dose Syringe, Compounded | 08082019@6 | 11/6/2019 |
| LIDOcaine HCl (Preservative Free) 20mg/mL (2%) 5mL Fill in a 6mL Single-Dose Syringe, Compounded | 08152019@10 | 11/13/2019 |
| Lidocaine HCl 3% (30mg/mL)& Hyaluronidase 15units/mL (75units/5mL)(PF) Opht Inj 5mL Syr, Compounded | 08062019@10 | 9/20/2019 |
| Lidocaine HCl 3% (30mg/mL)& Hyaluronidase 15units/mL (75units/5mL)(PF) Opht Inj 5mL Syr, Compounded | 08062019@10 | 9/20/2019 |
| Lidocaine HCl 3% (30mg/mL)& Hyaluronidase 15units/mL (75units/5mL)(PF) Opht Inj 5mL Syr, Compounded | 08152019@12 | 9/29/2019 |
| Lidocaine HCl 3% (30mg/mL)& Hyaluronidase 15units/mL (75units/5mL)(PF) Opht Inj 5mL Syr, Compounded | 08152019@12 | 9/29/2019 |
| LIDOCAINE(2%)/BUPIVACAINE(0.375%)/HYALURONIDASE(3U)20MG/3.75MG/3U/ML(PF)5 ML IN 6 ML SYR, COMPOUNDED | 08052019@8 | 9/19/2019 |
| LIDOCAINE(2%)/BUPIVACAINE(0.375%)/HYALURONIDASE(3U)20MG/3.75MG/3U/ML(PF)5 ML IN 6 ML SYR, COMPOUNDED | 08052019@8 | 9/19/2019 |
| LIDOCAINE(2%)/BUPIVACAINE(0.375%)/HYALURONIDASE(3U)20MG/3.75MG/3U/ML(PF)5 ML IN 6 ML SYR, COMPOUNDED | 08152019@3 | 9/29/2019 |
| LIDOCAINE(2%)/BUPIVACAINE(0.375%)/HYALURONIDASE(3U)20MG/3.75MG/3U/ML(PF)5 ML IN 6 ML SYR, COMPOUNDED | 08152019@3 | 9/29/2019 |
| METHIONINE/INOSITOL/CHOLINE/B6/CYANO-B12, COMPOUNDED 25/50/50/50/1 MG/ML ***LYO*** 30ML | 04192019@4 | 10/16/2019 |
| METHIONINE/INOSITOL/CHOLINE/B6/CYANO-B12, COMPOUNDED 25/50/50/50/1 MG/ML ***LYO*** 30ML | 06102019@1 | 12/7/2019 |
| METHYLCOBALAMIN 1MG/ML INJ 30 ML | 07182019@6 | 10/16/2019 |
| MGCL2.HEX/CAGLUC 82.5 MG/30 MG/ML (PF) INJ 10 ML, COMPOUNDED | 07252019@4 | 10/23/2019 |
| Moxifloxacin 0.1% (0.25mg/0.25mL)(CP) in Balanced Salt Solution Oph Inj 0.25mL Syringe, Compounded | 06252019@10 | 9/23/2019 |
| Moxifloxacin 0.1% (0.25mg/0.25mL)(CP) in Balanced Salt Solution Oph Inj 0.25mL Syringe, Compounded | 06252019@11 | 9/23/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 06252019@12 | 9/23/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 07142019@8 | 10/12/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 07172019@13 | 10/15/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 07182019@12 | 10/16/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 07242019@7 | 10/22/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08022019@1 | 10/31/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08022019@2 | 10/31/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08062019@1 | 11/4/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08082019@2 | 11/6/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08122019@1 | 11/10/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08122019@2 | 11/10/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08142019@5 | 11/12/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08192019@1 | 11/17/2019 |
| Moxifloxacin 0.1% (0.3mg/0.3mL)(CP) in Balanced Salt Solution Oph Inj 0.3mL Syringe, Compounded | 08202019@1 | 11/18/2019 |
| Neostigmine Methylsulfate 3mg/3 mL (1mg/mL) (Preservative Free) 3mL Single Dose Syr, Compounded | 06192019@10 | 9/17/2019 |
| Neostigmine Methylsulfate 3mg/3 mL (1mg/mL) (Preservative Free) 3mL Single Dose Syr, Compounded | 06192019@7 | 9/17/2019 |
| Neostigmine Methylsulfate 3mg/3 mL (1mg/mL) (Preservative Free) 3mL Single Dose Syr, Compounded | 06272019@6 | 9 |